Gutiérrez-Zúñiga R., Diez I., Bueichekú E., Kim C.-M., Orwig W., Montal V., Fuentes B., Díez-Tejedor E., Fernández M.G., Sepulcre J.. Connectomic-genetic signatures in the cerebral small vessel disease. NEUROBIOLOGY OF DISEASE. 2022; 167DOI:10.1016/j.nbd.2022.105671. PMID:35231560. IF:6.100(Q1/2D).

Moreau, M, Carmona-Iragui, M, Altuna, M, Dalzon, L, Barroeta, I, Vilaire, M, Durand, S, Fortea, J, Rebillat, AS, Janel, N. DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients. Biomedicines. 2022; 10(6)DOI:10.3390/biomedicines10061380. PMID:35740400. IF:4.700(Q1/3D).

Ramírez S., Haddad-Tóvolli R., Radosevic M., Toledo M., Pané A., Alcolea D., Ribas V., Milà-Guasch M., Pozo M., Obri A., Eyre E., Gómez-Valadés A.G., Chivite I., Van Eeckhout T., Zalachoras I., Altirriba J., Bauder C., Imbernón M., Garrabou G., Garcia-Ruiz C., Nogueiras R., Soto D., Gasull X., Sandi C., Brüning J.C., Fortea J., Jiménez A., Fernández-Checa J.C., Claret M.. Hypothalamic pregnenolone mediates recognition memory in the context of metabolic disorders. Cell Metabolism. 2022; 34(2)DOI:10.1016/j.cmet.2021.12.023. PMID:35108514. IF:29.000(Q1/1D).

Delaby, C, Bousiges, O, Bouvier, D, Fillee, C, Fourier, A, Mondesert, E, Nezry, N, Omar, S, Quadrio, I, Rucheton, B, Schraen-Maschke, S, van Pesch, V, Vicca, S, Lehmann, S, Bedel, A. Neurofilaments contribution in clinic: state of the art. Frontiers in Aging Neuroscience. 2022; 14DOI:10.3389/fnagi.2022.1034684. PMID:36389064. IF:4.800(Q2/3D).

Guillén, N, Contador, J, Buongiorno, M, Alvarez, I, Culell, N, Alcolea, D, Lleó, A, Fortea, J, Piñol-Ripoll, G, Carnes-Vendrell, A, Ispierto, ML, Vilas, D, Puig-Pijoan, A, Fernández-Lebrero, A, Balasa, M, Sánchez-Valle, R, Lladó, A. Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2025; 275(1)DOI:10.1007/s00406-023-01701-y. PMID:37898567. IF:3.700(Q1/3D).

Dols-Icardo, O, Carbayo, A, Jericó, I, Blasco-Martínez, O, Alvarez-Sánchez, E, Pérez, MAL, Bernal, S, Rodríguez-Santiago, B, Cusco, I, Turon-Sans, J, Cabezas-Torres, M, Caballero-Avila, M, Vesperinas, A, Llansó, L, Pagola-Lorz, I, Torné, L, Valle-Tamayo, N, Muñoz, L, Rubio-Guerra, S, Illán-Gala, I, Cortés-Vicente, E, Gelpi, E, Rojas-García, R. Identification of a pathogenic mutation in ARPP21 in patients with amyotrophic lateral sclerosis. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2025; 96(2)DOI:10.1136/jnnp-2024-333834. PMID:38960585. IF:7.500(Q1/1D).

Rubenstein, E, Tewolde, S, Michals, A, Weuve, J, Fortea, J, Fox, MP, Jimenez, MP, Scott, A, Tripodis, Y, Skotko, BG. Alzheimer Dementia Among Individuals With Down Syndrome. JAMA Network Open. 2024; 7(9)DOI:10.1001/jamanetworkopen.2024.35018. PMID:39312235. IF:9.700(Q1/1D).

Rubenstein, E, Tewolde, S, Skotko, BG, Michals, A, Fortea, J. Occurrence of mosaic Down syndrome and prevalence of co-occurring conditions in Medicaid enrolled adults, 2016-2019. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS. 2024; 196(4)DOI:10.1002/ajmg.c.32097. PMID:38925597. IF:4.400(Q1/2D).

Lleó, A, Alcolea, D. What Can Blood Biomarkers Tell Us About Patients With Lewy Body Dementia?. NEUROLOGY. 2024; 102(12)DOI:10.1212/WNL.0000000000209505. PMID:38830183. IF:8.500(Q1/1D).

Navarro-Pérez, MP, González-Quintanilla, V, Muñoz-Vendrell, A, Madrigal, E, Alpuente, A, Latorre, G, Molina, F, Monzón, MJ, Medrano, V, García-Azorín, D, González-Oria, C, Gago-Veiga, A, Velasco, F, Beltrán, I, Morollón, N, Viguera, J, Casas-Limón, J, Rodriguez-Vico, J, Cuadrado, E, Irimia, P, Iglesias, F, Guerrero-Peral, áL, Belvís, R, Pozo-Rosich, P, Pascual, J, Santos-Lasaosa, S. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study. Frontiers in Neurology. 2024; 15DOI:10.3389/fneur.2024.1417831. PMID:38938776. IF:2.800(Q2/5D).

Carbayo, A, Borrego-Écija, S, Turon-Sans, J, Cortés-Vicente, E, Molina-Porcel, L, Gascón-Bayarri, J, Rubio, MA, Povedano, M, Gámez, J, Sotoca, J, Juntas-Morales, R, Almendrote, M, Marquié, M, Sánchez-Valle, R, Illán-Gala, I, Dols-Icardo, O, Rubio-Guerra, S, Bernal, S, Caballero-Avila, M, Vesperinas, A, Gelpi, E, Rojas-García, R. Clinicopathological correlates in the frontotemporal lobar degeneration-motor neuron disease spectrum. BRAIN. 2024; 147(7)DOI:10.1093/brain/awae011. PMID:38227807. IF:11.700(Q1/1D).

Jacobs, T, Jacobson, SR, Fortea, J, Berger, JS, Vedvyas, A, Marsh, K, He, TS, Gutierrez-Jimenez, E, Fillmore, NR, Gonzalez, M, Figueredo, L, Gaggi, NL, Plaska, CR, Pomara, N, Blessing, E, Betensky, R, Rusinek, H, Zetterberg, H, Blennow, K, Glodzik, L, Wisniweski, TM, de Leon, MJ, Osorio, RS, Ramos-Cejudo, J. The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people. Immunity & Ageing. 2024; 21(1)DOI:10.1186/s12979-024-00435-2. PMID:38760856. IF:5.600(Q1/1D).

Fortea, J, McGlinchey, E, Espinosa, JM, Rafii, MS. Addressing challenges in health care and research for people with Down syndrome. LANCET. 2024; 403(10439)DOI:10.1016/S0140-6736(24)00478-1. PMID:38521088. IF:88.500(Q1/1D).

Delaby, C, Lehmann, S. On the road to biological blood diagnosis of Alzheimer's disease?. M S-MEDECINE SCIENCES. 2024; 40(4)DOI:10.1051/medsci/2024037. PMID:38651960. IF:0.400(Q4/10D).

García-Azorín, D, Martínez-Badillo, C, Muñiz, JC, Gago-Veiga, AB, Sánchez, NM, González-Quintanilla, V, Porta-Etessam, J, Sierra-Mencia, A, Gonzalez-Garcia, N, González-Osorio, Y, Polanco-Fernandez, M, Recio-García, A, Nieto, RB, Guerrero-Peral, AL. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine. CEPHALALGIA. 2024; 44(4)DOI:10.1177/03331024241248833. PMID:38663908. IF:4.600(Q1/2D).

Swift, IJ, Rademakers, R, Finch, N, Baker, M, Ghidoni, R, Benussi, L, Binetti, G, Rossi, G, Synofzik, M, Wilke, C, Mengel, D, Graff, C, Takada, LT, Sanchez-Valle, R, Antonell, A, Galimberti, D, Fenoglio, C, Serpente, M, Arcaro, M, Schreiber, S, Vielhaber, S, Arndt, P, Santana, I, Almeida, MR, Moreno, F, Barandiaran, M, Gabilondo, A, Stubert, J, Gomez-Tortosa, E, Agueero, P, Sainz, MJ, Gohda, T, Murakoshi, M, Kamei, N, Kittel-Schneider, S, Reif, A, Weigl, J, Jian, JL, Liu, CJ, Serrero, G, Greither, T, Theil, G, Lohmann, E, Gazzina, S, Bagnoli, S, Coppola, G, Bruni, A, Quante, M, Kiess, W, Hiemisch, A, Jurkutat, A, Block, MS, Carlson, AM, Bråthen, G, Sando, SB, Grontvedt, GR, Lauridsen, C, Heslegrave, A, Heller, C, Abel, E, Gómez-Núñez, A, Puey, R, Arighi, A, Rotondo, E, Jiskoot, LC, Meeter, LHH, Duraes, J, Lima, M, Tábuas-Pereira, M, Lemos, J, Boeve, B, Petersen, RC, Dickson, DW, Graff-Radford, NR, Leber, I, Sellami, L, Lamari, F, Clot, F, Borroni, B, Cantoni, V, Rivolta, J, Lleó, A, Fortea, J, Alcolea, D, Illán-Gala, I, Andres-Cerezo, L, Van Damme, P, Clarimon, J, Steinacker, P, Feneberg, E, Otto, M, van der Ende, EL, van Swieten, JC, Seelaar, H, Zetterberg, H, Sogorb-Esteve, A, Rohrer, JD. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors. Alzheimers Research & Therapy. 2024; 16(1)DOI:10.1186/s13195-024-01420-z. PMID:38539243. IF:7.600(Q1/1D).

Pardo, J, Montal, V, Campabadal, A, Oltra, J, Uribe, C, Roura, I, Bargalló, N, Martí, MJ, Compta, Y, Iranzo, A, Fortea, J, Junqué, C, Segura, B. Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder. MOVEMENT DISORDERS. 2024; 39(5)DOI:10.1002/mds.29761. PMID:38456361. IF:7.600(Q1/1D).

Ashton N.J., Brum W.S., Di Molfetta G., Benedet A.L., Arslan B., Jonaitis E., Langhough R.E., Cody K., Wilson R., Carlsson C.M., Vanmechelen E., Montoliu-Gaya L., Lantero-Rodriguez J., Rahmouni N., Tissot C., Stevenson J., Servaes S., Therriault J., Pascoal T., Lleó A., Alcolea D., Fortea J., Rosa-Neto P., Johnson S., Jeromin A., Blennow K., Zetterberg H.. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurology. 2024; 81(3)DOI:10.1001/jamaneurol.2023.5319. PMID:38252443. IF:21.300(Q1/1D).

Lorca-Puls DL, Gajardo-Vidal A, Mandelli ML, Illán-Gala I, Ezzes Z, Wauters LD, Battistella G, Bogley R, Ratnasiri B, Licata AE, Battista P, García AM, Tee BL, Lukic S, Boxer AL, Rosen HJ, Seeley WW, Grinberg LT, Spina S, Miller BL, Miller ZA, Henry ML, Dronkers NF, Gorno-Tempini ML. Neural basis of speech and grammar symptoms in non-fluent variant primary progressive aphasia spectrum. BRAIN. 2024; 147(2)DOI:10.1093/brain/awad327. PMID:37769652. IF:11.700(Q1/1D).

Bejanin, A, Villain, N. Posterior cortical atrophy: new insights into treatments and biomarkers for Alzheimer's disease. LANCET NEUROLOGY. 2024; 23(2)DOI:10.1016/S1474-4422(23)00501-X. PMID:38267172. IF:45.500(Q1/1D).